SABCS 2024 Noteworthy Abstracts in Early Breast Cancer

Sara Tolaney

H. Rugo

ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive & Clini…

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

Clinical Applications of ctDNA in Breast Cancer Diagnosis and Manage…

University of Miami Sylvester Comprehensive Cancer Center

D. Tripathy

ESMO 2024 Summary: The Emerging Global Epidemic of Early-Onset Cance…

2024 ESMO Annual Meeting Insights Hub

S. Ogino

Visible vs. Invisible Cancers - The Genomics and Natural History

Laurence Klotz

Cancer Genomics: Molecular Profile Interpretation 101

Total Health

L. Welch

New Frontiers in Oncology: Advanced Diagnostics and Therapeutics

Springer Healthcare IME

S. Peters

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

ACP 2024 Insights: Cancer of Unknown Primary

Insights from 2024 ACP Annual Meeting

S. Brondfield

Management of Higher Risk eBC Including BRCAm, HER2- Subtypes

2024 ASCO® Annual Meeting Insights Hub

M. Dolezal

Understanding CRISPR and Gene Editing in the Treatment of Heme Malig…

UChicago Medicine

A. Cooper

PET/MR Molecular Imaging of Cancer

Yale Cancer Center

G. El Fakhri

Endocrine Adverse Events From Checkpoint Inhibitors

Yale Cancer Center

K. Herold

Unequal Outcomes: Disparities in Breast Cancer for Black Women

Tiffany Onger

Novel Approaches in Oncology: Early Interception & BRCA Advances in …

Houston Methodist

P. Munster

The TAPUR Study: Evaluating Targeted Therapies Based on Genetic Alte…

University of Miami Sylvester Comprehensive Cancer Center

R. Schilsky

Oncologic Emergencies: The Clock Is Ticking

Medical College of Georgia - Augusta University

G. Raval

2L Therapy for ER+ mBC Following CDK4/6i

James Martin

BRCA2 Mutations and Hereditary Cancer Risk

Houston Methodist

P. Munster